VYCOR MEDICAL, INC. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- VYCOR MEDICAL, INC. stock issued during period, value, other for the quarter ending 2022-09-30 was $56.79K, a 26.39% decline year-over-year.
- VYCOR MEDICAL, INC. stock issued during period, value, other for the quarter ending 2022-06-30 was $86.13K, a 8.95% decline year-over-year.
- VYCOR MEDICAL, INC. stock issued during period, value, other for the quarter ending 2022-03-31 was $45.54K, a 55.11% decline year-over-year.
- VYCOR MEDICAL, INC. stock issued during period, value, other for the quarter ending 2021-12-31 was $51.97K, a 53.81% decline year-over-year.
- VYCOR MEDICAL, INC. stock issued during period, value, other for fiscal 2021 was $325.13K, a 27.75% decline from fiscal 2020.
- VYCOR MEDICAL, INC. stock issued during period, value, other for fiscal 2020 was $450.00K, a 0.21% decline from fiscal 2019.
- VYCOR MEDICAL, INC. stock issued during period, value, other for fiscal 2019 was $450.94K.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2022-09-30 | $56.79K 10-Q · filed 2022-11-14 | $240.41K derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-06-30 | $86.13K 10-Q · filed 2022-08-15 | $260.77K derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-03-31 | $45.54K 10-Q · filed 2022-05-10 | $269.24K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-12-31 | $51.97K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-13 | $325.13K 10-K · filed 2022-04-13 |
| 2021-09-30 | $77.14K 10-Q · filed 2022-11-14 | $385.67K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $94.59K 10-Q · filed 2022-08-15 | $421.02K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $101.43K 10-Q · filed 2022-05-10 | $438.93K derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $112.50K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-13 | $450.00K 10-K · filed 2022-04-13 |
| 2020-09-30 | $112.50K 10-Q · filed 2021-11-12 | $450.00K derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $112.50K 10-Q · filed 2021-08-16 | $450.00K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $112.50K 10-Q · filed 2021-05-14 | $450.94K derived: sum of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | $112.50K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $450.94K 10-K · filed 2021-03-31 |
| 2019-09-30 | $112.50K 10-Q · filed 2020-11-13 | |
| 2019-06-30 | $113.44K 10-Q · filed 2020-08-17 |